These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31888870)

  • 1. France removes state funding for dementia drugs.
    Walsh S; King E; Brayne C
    BMJ; 2019 Dec; 367():l6930. PubMed ID: 31888870
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE and anti-dementia drugs: a triumph of health economics over clinical wisdom?
    O'Brien JT
    Lancet Neurol; 2006 Dec; 5(12):994-6. PubMed ID: 17110274
    [No Abstract]   [Full Text] [Related]  

  • 3. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Winblad B; Hill S; Beermann B; Post SG; Wimo A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():39-45. PubMed ID: 9305515
    [No Abstract]   [Full Text] [Related]  

  • 4. Harbinger of hope or commodity fetishism: "re-cognizing" dementia in an age of therapeutic agents.
    Graham JE
    Int Psychogeriatr; 2001 Jun; 13(2):131-4. PubMed ID: 11495389
    [No Abstract]   [Full Text] [Related]  

  • 5. Experts disagree over NICE's approach for assessing drugs.
    Hoey R
    Lancet; 2007 Aug; 370(9588):643-4. PubMed ID: 17726791
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidementia drugs: are they effective in improving quality of life for elderly persons with dementia?
    Homma A
    Int Psychogeriatr; 1995; 7(3):363-6. PubMed ID: 8821343
    [No Abstract]   [Full Text] [Related]  

  • 7. A systematic review of the cost-effectiveness of interventions for supporting informal caregivers of people with dementia residing in the community.
    Jones C; Edwards RT; Hounsome B
    Int Psychogeriatr; 2012 Jan; 24(1):6-18. PubMed ID: 21813034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between elderly suicide rates and the affordability of psychotropic drugs.
    Shah A; Bhatia G
    Int Psychogeriatr; 2009 Feb; 21(1):204-5. PubMed ID: 18634616
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethics and the anti-dementia drugs.
    Hughes JC
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):538-43. PubMed ID: 10861921
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosing and treating dementia in German primary and specialized care between 2011 and 2015
.
    Michalowsky B; Kostev K; Iliffe S; Hoffmann W; Bohlken J
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):301-309. PubMed ID: 29701170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nootropic drugs: definition, classification, mechanism of action, clinical effectiveness, substances].
    Kuhlmey J
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):697-701. PubMed ID: 7975756
    [No Abstract]   [Full Text] [Related]  

  • 13. Economics of dementia and pharmacoeconomics of dementia therapy.
    Fillit H; Hill J
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):39-49. PubMed ID: 16089246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nootropic drug evaluation for general practice].
    Ihl R; Kretschmar C
    Nervenarzt; 1997 Nov; 68(11):853-61. PubMed ID: 9732727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dementia of trisomy 21. Improvement with donepezil].
    Schill D
    Med Monatsschr Pharm; 2005 Oct; 28(10):371-2. PubMed ID: 16245462
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic evaluation of donepezil treatment for Alzheimer's disease in Japan.
    Ikeda S; Yamada Y; Ikegami N
    Dement Geriatr Cogn Disord; 2002; 13(1):33-9. PubMed ID: 11731713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 18. Nefiracetam. DM 9384, DZL 221, Translon.
    Drugs R D; 1999 Aug; 2(2):137-41. PubMed ID: 10820661
    [No Abstract]   [Full Text] [Related]  

  • 19. Yokukansan treatment in chronic renal failure patients with dementia receiving hemodialysis: an open label study.
    Sumiyoshi H; Mantani A; Nishiyama S; Fujiwaki S; Ohta S; Masuda Y; Tomita Y; Tarumoto N; Yamawaki S
    Am J Geriatr Psychiatry; 2011 Oct; 19(10):906-7. PubMed ID: 21795962
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Post SG; Beerman B; Brodaty H; Gaines AW; Gauthier SG; Geldmacher DS; Hill S; Homma A; Rossor MN; Whitehouse PJ; Winblad B
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():26-8. PubMed ID: 9305511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.